Context Therapeutics grants new hire stock options for 146,000 shares at $0.7 each
CNTX•Grant terms
The grant date was July 7, 2026, and the exercise price was set at $0.70 per share, matching the Nasdaq close.
The options carry a 10-year term and vest over four years: 25% after one year, then monthly over the following 36 months.
New hire stock option grant
Context Therapeutics granted a non-qualified stock option for 146,000 shares to a new employee, issued as an inducement award.
